Inozyme Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Inozyme Pharma, Inc. has filed 378 SEC EDGAR filings since 05 Jan 2017

SEC filing history

Showing 226-250 of 378 matching filings.

Per page
25
Current page
10
SC 13G/A File 005-91586

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91586

SC 13G/A filing

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91586

INOZYME PHARMA, INC.

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91586

NEW ENTERPRISE ASSOCIATES 15, L.P. / INOZYME PHARMA -- 13GA(#1)

Filing date
07 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91586

SCHEDULE 13G/A

Filing date
15 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-258702

EFFECT filing

Filing date
23 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
18 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-258702

S-3

Filing date
11 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39397

INZY_10-Q_6312021

Filing date
11 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-39397

8-K

Filing date
11 Aug 2021
Reporting date
11 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91586

SC 13D/A

Filing date
30 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2021
Reporting date
24 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39397

FORM 4 SUBMISSION

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39397

8-K

Filing date
24 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .